Company
introduction
introduction
Dongsung pharmaceutical with 60 years of history provides customer oriented total services and future oriented marketing which covers cosmetics and finished medicine.
| Product name | : | Amvalt Tab. 5/160mg |
|---|---|---|
| Product division | : | ETC drug |
| Classification group | : | Circulatory medication |
| Insurance code | : | 643202420 |
| Efficacy and effect | : | Essential hypertension th.. |
Basic information
-
- Appearance
-
Amvalt 5/80mg : Dark yellow round film-coated tablet
Amvalt 5/160mg : Dark yellow oval film-coated tablet
-
- DOSAGE AND ADMINISTRATION
-
The recommended dose of this drug is 1 tablet per day, taken with water, regardless of diet. If possible, it is recommended that you take it at the same time every day (eg morning).
It is recommended that the dose be adjusted with the individual components (amlodipine or valsartan) prior to administration of this drug, but if the blood pressure is not controlled by monotherapy for the individual components as follows, immediate conversion to this drug may be considered.
* 5/80 milligrams: 5 mg of amlodipine or 80 mg of valsartan monotherapy is administered to patients whose blood pressure is not adequately controlled.
* 5/160 milligrams: 5 mg of amlodipine or 160 mg of valsartan monotherapy is administered to patients whose blood pressure is not adequately controlled.
* 10/160 mg: Amlodipine 10 milligrams or valsartan 160 milligrams monotherapy or 5/160 milligrams is administered to patients whose blood pressure is not adequately controlled.
Patients taking valsartan and amlodipine in combination may be able to switch to this drug (a combination with identical content of individual substances) for ease of administration.
Patients with renal impairment: patients with mild and moderate renal impairment (creatinine clearance> 10 mL / min) do not require dose adjustment, but patients with severe renal impairment (creatinine clearance <10 mL / min) and dialysis patients shoud not be prescribed with the drug. For patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended.
Patients with hepatic impairment: For patients with mild to moderate hepatic impairment, the daily dose of valsartan should not exceed 80 mg. Patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction or cholestasis should not be administered.
Elderly people 65 years of age or older: Use caution when increasing the dose.
Pediatric: Safety and efficacy of pediatric patients under the age of 18 years has not been established, therefore this drug is not recommended for use.
-
- Ingredient / content
-
per 1 tablet
Amvalt tab. 5/80mg
- Amlodipine besylate (5 mg as amlodipine) 6.94 mg
- Valsartan 80mg
Amvalt tab 5/160mg
- Amlodipine besylate (5 mg as amlodipine) 6.94 mg
- Valsartan 160mg
-
- standard
- 28 tablet
-
- How to Save
- Airtight container, Store at room temperature (1~30℃)
-
- Efficacy and effect
- Essential hypertension that cannot be controlled with sole usage of amrodipine or Valsartan
DONGSUNG BIO PHARM SNS
